| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.42M | — |
| Operating expense | — | — |
| Net income | -20.67M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CTMX returned +54.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -23.0% |
| 1 year | +54.7% |
| 5 years | -35.9% |
| 10 years | -72.0% |
| All-time high | $29.71 (Feb 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CTMX would be worth today ›No. CytomX Therapeutics, Inc. has not paid a dividend in the past 12 months.
CytomX Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CTMX.
CytomX Therapeutics, Inc. is part of the Healthcare sector.
CytomX Therapeutics, Inc. has a market cap of 714.71M USD, based on the latest quote.
CytomX Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
